Esperion Therapeutics, Inc.
ESPR
ESPR: Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment.
moreShow ESPR Financials
Recent trades of ESPR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ESPR's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on ESPR's company Twitter account
Number of mentions of ESPR in WallStreetBets Daily Discussion
Recent insights relating to ESPR
Recent picks made for ESPR stock on CNBC
ETFs with the largest estimated holdings in ESPR
Flights by private jets registered to ESPR